Show simple item record

Files in this item

FilesSizeFormatView

There are no files associated with this item.

Item metadata

dc.contributor.advisorGillespie, S. H.
dc.contributor.advisorSloan, Derek James
dc.contributor.authorDombay, Evelin
dc.coverage.spatial335 p.en_US
dc.date.accessioned2021-10-11T15:24:49Z
dc.date.available2021-10-11T15:24:49Z
dc.date.issued2021-11-30
dc.identifier.urihttps://hdl.handle.net/10023/24110
dc.description.sponsorship"This work was supported by the Pan-African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA), grant agreement reference number TRIA2015-1102, and financial contribution from European & Developing Countries Clinical Trials Partnership (EDCTP)." -- Acknowledgementsen
dc.language.isoenen_US
dc.publisherUniversity of St Andrews
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.lccRC311.4D7
dc.titleInvestigation of novel biomarkers of tuberculosis (TB) treatment response in clinical trials and clinical practiceen_US
dc.typeThesisen_US
dc.contributor.sponsorEuropean & Developing Countries Clinical Trials Partnership (EDCTP)en_US
dc.contributor.sponsorPan-African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA)en_US
dc.type.qualificationlevelDoctoralen_US
dc.type.qualificationnamePhD Doctor of Philosophyen_US
dc.publisher.institutionThe University of St Andrewsen_US
dc.rights.embargodate2024-09-16
dc.rights.embargodateThesis restricted in accordance with University regulations. Print and electronic copy restricted until 16th September 2024en
dc.identifier.doihttps://doi.org/10.17630/sta/142
dc.identifier.grantnumberTRIA2015-1102en_US


The following licence files are associated with this item:

    This item appears in the following Collection(s)

    Show simple item record

    Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
    Except where otherwise noted within the work, this item's licence for re-use is described as Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International